Blueprint Hits Study Goal With Main Drug Avapritinib, Additional Studies Being AdvancedSeeking Alpha • 03/24/20
Blueprint Medicines Corporation: An Undervalued Company With Attractive ProspectsSeeking Alpha • 03/20/20
Why Is Blueprint Medicines (BPMC) Down 21.6% Since Last Earnings Report?Zacks Investment Research • 03/14/20
Blueprint Medicines Corporation's (BPMC) CEO Jeff Albers on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/13/20
Legendary Biotech Pioneer Fires a Shot Across Healthcare Industry's Bottom LineThe Motley Fool • 01/13/20
Why Is Blueprint Medicines (BPMC) Up 1.4% Since Last Earnings Report?Zacks Investment Research • 12/05/19
Blueprint Medicines (BPMC) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 11/21/19